Download - WHOCC

QH02
CORTICOSTEROIDS FOR SYSTEMIC USE
As a general rule, systemic corticosteroids should be classified in this group. There
is, however, one exception: QM01BA - Antiinflammatory antirheumatic agents in
combination with corticosteroids.
Corticosteroids for local oral treatment, see QA01AC.
Corticosteroids for topical use, see QD07.
Corticosteroids in combination with antiinfectives/antiseptics for local treatment of
gynecological infections, see QG01B and for intrauterine infections, see QG51B.
Corticosteroids for inhalation, see QR03B.
Corticosteroids, eye/ear products, see QS.
QH02A
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Only plain preparations are classified in this group. The group also includes
corticosteroid preparations for local injection.
QH02AA
QH02AB
Mineralocorticoids
Glucocorticoids
QH02B
GLUCOCORTICOIDS FOR SYSTEMIC USE, COMBINATIONS
This group comprises all combined preparations, e.g. combinations with local
anesthetics.
QH02BX
Corticosteroids for systemic use, combinations
QH02C
QH02CA
ANTIADRENAL PREPARATIONS
Anticorticosteroids
QH03
QH03A
THYROID THERAPY
THYROID PREPARATIONS
Thyroid extracts and synthetic analogues used in the treatment of hypothyrosis
should be classified in this group.
QH03AA
Thyroid hormones
Natural and synthetic thyroid hormones should be classified in this group.
Combinations of levothyroxine and liothyronine are classified using the ATCvet
5th level code QH03AA03.
86